Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Diabetes

Free Subscription Articles published in Am Heart J Retrieve available abstracts of 17 articles: HTML format Text format

Single Articles

November 2011
1. CASTAGNO D , Baird-Gunning J, Jhund PS, Biondi-Zoccai G, et al
   Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: Evidence from a 37,229 patient meta-analysis.
   Am Heart J. 2011;162:938-948.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. SCIRICA BM , Bhatt DL, Braunwald E, Steg PG, et al
   The design and rationale of the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus-Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 Study.
   Am Heart J. 2011;162:818-825.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. AGUILAR D
   Heart failure and diabetes: Time to pay attention.
   Am Heart J. 2011;162:795-7.
   PubMed     Text format     Related articles   
   
   
   
   October 2011
4. MCMURRAY JJ , Uno H, Jarolim P, Desai AS, et al
   Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT).
   Am Heart J. 2011;162:748-755.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. KUFNER S , de Waha A, Tomai F, Park SW, et al
   A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease.
   Am Heart J. 2011;162:740-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. SHAH AM , Hung CL, Shin SH, Skali H, et al
   Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both.
   Am Heart J. 2011;162:685-91.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. WHITE WB , Bakris GL, Bergenstal RM, Cannon CP, et al
   EXamination of CArdiovascular OutcoMes with AlogliptIN versus Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome (EXAMINE) A cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients
   Am Heart J. 2011;162:620-626.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. RIDKER PM , Thuren T, Zalewski A, Libby P, et al
   Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).
   Am Heart J. 2011;162:597-605.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
9. KAPOOR JR , Fonarow GC, Zhao X, Kapoor R, et al
   Diabetes, quality of care, and in-hospital outcomes in patients hospitalized with heart failure.
   Am Heart J. 2011;162:480-486.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
10. HAGE FG , Dean P, Bhatia V, Iqbal F, et al
    The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease.
    Am Heart J. 2011;162:356-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. ELBAROUNI B , Ismaeil N, Yan RT, Fox KA, et al
    Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes.
    Am Heart J. 2011;162:347-355.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
12. CHUNG SC , Hlatky MA, Stone RA, Rana JS, et al
    Body mass index and health status in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial (BARI 2D).
    Am Heart J. 2011;162:184-192.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. MARENZI G , De Metrio M, Bartorelli AL
    Author's reply to Acute hyperglycemia: Is really a new risk marker for contrast-induced nephropathy in patients with acute myocardial infarction without diabetes and normal renal function?
    Am Heart J. 2011;162:e9.
    PubMed     Text format     Related articles   
    
    
    
    
14. RAPOSEIRAS-ROUBIN S , Pardal CB, Ocaranza R, Cid B, et al
    Acute hyperglycemia: Is really a new risk marker for contrast-induced nephropathy in patients with acute myocardial infarction without diabetes and normal renal function?
    Am Heart J. 2011;162:e7.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
15. BEOHAR N , Davidson CJ, Massaro EM, Srinivas VS, et al
    The impact of race/ethnicity on baseline characteristics and the burden of coronary atherosclerosis in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
    Am Heart J. 2011;161:755-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. BRITTON KA , Aggarwal V, Chen AY, Alexander KP, et al
    No association between hemoglobin A1c and in-hospital mortality in patients with diabetes and acute myocardial infarction.
    Am Heart J. 2011;161:657-663.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
17. HOLPER EM , Abbott JD, Mulukutla S, Vlachos H, et al
    Temporal changes in the outcomes of patients with diabetes mellitus undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute dynamic registry.
    Am Heart J. 2011;161:397-403.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: